Request for Applications for Basic, Clinical or Translational Lupus Research In Pediatric HRQOL
On behalf of the Michael Jon Barlin
Pediatric Research Program,
The Lupus Foundation of America, Inc.
Issues the Following
Request for Applications for
Basic, Clinical or Translational Lupus Research
In Pediatric HRQOL
RFA 009-02 (P)
 |
| Michael Jon Barlin |
On behalf of the Michael Jon Barlin Pediatric Research Program, the Lupus Foundation of America, Inc. (LFA) is issuing this Request for Applications (RFA) that address key understanding of lupus research issues involving potential therapeutics and/or diagnostic tools related to pediatric and/or adolescent lupus research.
Lupus in children may develop early and tends to be more severe with multi-organ system involvement. The genetic and hormonal influences in children with lupus may be more amenable to dissection by clearly defined research studies. New diagnostic and prognostic tests, as well as directed therapeutic interventions, are still needed. Early therapeutic intervention may affect the later development of sequellae of disease and therapy as these children become adults.
Research Objectives:
This RFA seeks applications that address key understanding of pediatric lupus research issues in order to better understand pSLE features and societal factors that affect the HRQOL of children, adolescents and young adults by providing start-up funds to initiate new studies that address one or more of the following areas:
- The development and validation of tools to measure quality of life in children with pSLE.
- Further understanding of the impact of pSLE on HRQOL with focus on the validation of generic and disease specific measures.
- Impact of age, gender, race and or ethnicity on the various aspects of HRQOL with pSLE.
- Determination of risk factors for low HRQOL for various groups of patients with pSLE including, but not limited to, access to care, insurance status and reaching young adulthood.
- Development and testing of clinical interventions that improve the HRQOL with pSLE, such as approaches to health care delivery, transitioning programs or interventions that improve adherence.
Funding Opportunity:
RFA 009-02 (P) will provide one, one-year grant of $70,000 with a potential for second-year funding. Research projects should either come from investigators at the level of Instructor, Assistant Professor or above without substantial funding (e.g. R01 or R01 equivalent) or with a new lupus-specific research proposal which is not or has not been already funded.
Download RFA Guidelines here. (PDF)
- BINDING LETTER OF INTENT MUST BE SUBMITTED BY JULY 13, 2009 (this deadline has been extended from July 3)
- ONLINE APPLICATIONS MUST BE SUBMITTED BY AUGUST 7, 2009
- AWARD ANNOUNCEMENT DATE the week of September 21
For further details and / or to submit a Letter of Intent, please visit proposalCentral at http://proposalcentral.altum.com/.
A proposalCENTRAL helpline is available for questions from applicants during normal business hours (8:30 a.m. – 5:00 p.m. Eastern), Monday-Friday. Call toll-free 1-800-875-2562 x-227. In Maryland, call 301-916-4557 x-227. Or you can send an email to pcsupport@altum.com.
Connect with Us: